BioPharma Law Group PLLC
REMS Patents: Listability and Other Issues
Abstract: Are Risk Evaluation and Mitigation Strategy (REMS) patents Orange Book listable (or even should be)? A straightforward question with a lot of disagreement. This paper discusses recent litigation on...Read more
Joanna Brougher
Owner & Principal, BioPharma Law Group PLLC, USA